Cdc20 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-58408
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (95%), Rat (95%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: MAQFAFESDLHSLLQLDAPIPNAPPARWQRKAKEAAGPAPSPMRAANRSHSAGRTPGRTPGK
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for Cdc20 Antibody
Immunocytochemistry/ Immunofluorescence: Cdc20 Antibody [NBP2-58408]
Immunocytochemistry/Immunofluorescence: Cdc20 Antibody [NBP2-58408] - Staining of human cell line U-251 MG shows localization to nucleoplasm & cytosol.Applications for Cdc20 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Immunocytochemistry/Immunofluorescence Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Cdc20
Long Name
Cell division cycle protein 20 homolog
Alternate Names
p55CDC
Gene Symbol
CDC20
Additional Cdc20 Products
Product Documents for Cdc20 Antibody
Product Specific Notices for Cdc20 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...